ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Safety and Decreased Inflammation of Early Double Cytokine Blockade (IL-1β and TNF-α) Facilitates Engraftment in Islet Allotransplantation.

N. Onaca,1 M. Takita,2 M. Levy,3 B. Naziruddin.1

1Simmons Transplant Institute, Baylor University Medical Center, Dallas
2Baylor Scott and White Research Institute, Dallas
3Hume Lee Transplant Center, Virginia Commonwealth University, Richmond

Meeting: 2017 American Transplant Congress

Abstract number: C247

Keywords: Graft survival, Inflammation, Islets, Tumor necrosis factor (TNF)

Session Information

Session Name: Poster Session C: Pancreas and Islet (Auto and Allo) Transplantation

Session Type: Poster Session

Date: Monday, May 1, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Enhanced early islet engraftment offers the potential for improved graft function after islet allotransplantation (IT). Nine patients underwent IT under a fully completed prospective research protocol using double cytokine blockade with anti TNFα (ethanercept day 0, 3,7,10) and IL-1β (anakinra, day 0-7) at the time of each islet infusion, with anticoagulation. Mean islet infusion dose was 8,967 islet equivalents (IEq)/kg body weight (range 3582-6395), for a total dose per patient of 12,999 IEq/kg (range: 6842-24892) in 1 or 2 preparations (5 and 4 patients, respectively). Immunosuppression was achieved with tacrolimus, MMF, and induction with anti thymocyte globulin (7 patients) or alemtuzumab (2 patients). Islet damage markers (measured by microRNA375) were low. Peak liver enzymes (as a marker of inflammation/ischemia) were only 95+60 IU/ml for AST and 128+78 IU/ml for ALT by day 3-4 post IT. There were no thrombotic events and no infectious complications associated with combined IL1-β and TNF-α blockade. 6 patients became insulin independent, 2 had partial function, and one had primary non function (PNF). Two patients had a severe drop in serum C-peptide with new antiGAD65 antibody formation from day 28, followed by complete graft loss (one with preexisting antibody had PNF, the other developed de novo antibody and lost C-peptide at month 3); they were not retransplanted. Another patient died at home 16 months after IT, for unclear reasons, while being insulin independent. Upon completion of 24 months of follow-up, 6/9 patients have excellent glycemic control (fasting blood glucose, IVGGT, C-peptide), HbA1c < 6%, and no episodes of hypoglycemia unawareness. Eight patients developed HLA alloantibodies at various time points (class 1 – 5, class 2 – 6) with enhanced T cell alloreactivity. One patient retained good graft function despite having anti GAD65 antibodies. The use of double cytokine blockade is safe, with reduction of inflammation at transplantation and presumably with better engraftment. However, it does not influence later islet loss from T-cell mediated auto- and alloimmunity, which require different strategies in order to maintain long term islet function.

CITATION INFORMATION: Onaca N, Takita M, Levy M, Naziruddin B. Safety and Decreased Inflammation of Early Double Cytokine Blockade (IL-1β and TNF-α) Facilitates Engraftment in Islet Allotransplantation. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Onaca N, Takita M, Levy M, Naziruddin B. Safety and Decreased Inflammation of Early Double Cytokine Blockade (IL-1β and TNF-α) Facilitates Engraftment in Islet Allotransplantation. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/safety-and-decreased-inflammation-of-early-double-cytokine-blockade-il-1-and-tnf-facilitates-engraftment-in-islet-allotransplantation/. Accessed May 10, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences